Details for Patent: 6,096,341
✉ Email this page to a colleague
Summary for Patent: 6,096,341
Title: | Delayed release tablet of bupropion hydrochloride |
Abstract: | The invention provides a controlled release tablet, free of stabilizer and free of pore-forming agent comprising: (i) a core consisting essentially of bupropion hydrochloride, a binder and a lubricant; and (ii) a coating consisting essentially of a water-insoluble, water-permeable film-forming polymer, a plasticizer and a water-soluble polymer. |
Inventor(s): | Seth; Pawan (Irvine, CA) |
Assignee: | Pharma Pass LLC (Irvine, CA) |
Application Number: | 09/184,091 |
Patent Claim Types: see list of patent claims | Dosage form; Composition; Formulation; | More… ↓ |
Drugs Protected by US Patent 6,096,341
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |